iCAD Reports Financial Results for Third Quarter Ended September 30, 2024
November 13, 2024 16:01 ET
|
iCAD, Inc.
NASHUA, N.H., Nov. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically...
iCAD's ProFound Detection Version 4.0 Gains FDA Clearance
November 12, 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Nov. 12, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven AI-powered cancer detection solutions, announced today that...
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference
November 06, 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Nov. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically...
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024
November 05, 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Nov. 05, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial...
iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024
October 03, 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H. and PARIS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven AI-powered cancer detection solutions, today...
iCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 2024
September 11, 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Sept. 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically...
iCAD Reports Financial Results for Second Quarter Ended June 30, 2024
August 13, 2024 16:01 ET
|
iCAD, Inc.
NASHUA, N.H., Aug. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically...
iCAD to Report Second Quarter 2024 Financial Results on August 13, 2024
August 06, 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Aug. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial...
iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography
July 29, 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H. and WILLIAMSVILLE, N.Y. and RALEIGH, N.C., July 29, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today...
iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024
June 26, 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., June 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, today announced it will highlight new research...